Designates June 2019 as Nephrotic Awareness Month in Louisiana, and commends NephCure for their continued efforts in finding a cure for diseases and conditions of the kidneys.
The resolution itself does not directly change laws but serves to highlight existing issues related to kidney diseases. By designating June as 'Nephrotic Awareness Month', it aims to foster public awareness and encourage community engagement around kidney health, potentially influencing legislative attention and funding for investments in kidney disease research and patient care. It recognizes the vital role organizations like NephCure play in providing resources and support to families affected by nephrotic syndrome.
SCR95 is a Senate Concurrent Resolution that designates June 2019 as 'Nephrotic Awareness Month' in Louisiana, aimed at raising awareness about Nephrotic Syndrome and other related kidney diseases. The resolution specifically commends NephCure, an organization dedicated to finding treatments and cures for kidney conditions. The resolution acknowledges the significant prevalence of chronic kidney disease (CKD) in the United States, highlighting that many individuals are unaware of their kidney issues, which complicates treatment and care efforts.
The sentiment surrounding SCR95 is largely positive, as it promotes awareness and educates the public on nephrotic syndrome and various kidney diseases. Supporters of the resolution, including health advocates and organizations like NephCure, view it as a significant step towards enhancing understanding and highlighting the urgent need for awareness in the public sphere. By recognizing the month, the legislature is commending ongoing efforts and bringing attention to a critical health issue.
While the resolution is celebratory in nature, emphasizing awareness rather than introducing contentious provisions or legal changes, it does reflect an underlying challenge in public health. The acknowledgment of kidney diseases often being unnoticed underscores a critical gap in public knowledge and the healthcare system. Potential points of contention could arise if funding for kidney health initiatives or specific research agendas are debated in future legislative sessions, as financial resource allocation is often a topic of significant discussion.